Background and Purpose-Blood pressure (BP) control in the early phase of stroke is controversial to reduce the risk of poststroke cognitive impairment (PSCI). This study was to investigate the impact of BP levels in the early phase of ischemic stroke and stroke subtype on PSCI. Methods-Seven hundred and ninety-six patients with acute ischemic stroke were included. Cognitive function was assessed after stroke onset using the Montreal Cognitive Assessment. 
C ommonly, stroke survivors experience poststroke cognitive impairment (PSCI), ranging from mild cognitive impairment to severe poststroke dementia. 1 Epidemiological studies have reported that the overall prevalence of PSCI varies from 24% to 58% at 3 months after stroke. 2 Noticeably, PSCI is associated with the increased mortality, stroke recurrence, dependency, institutionalization, and higher costs of care, resulting in a huge burden on patients, their families, and healthcare resources. [3] [4] [5] Increasing evidences demonstrate that demographic characteristics, vascular risk factors, and stroke features are significant predictors of PSCI. 6, 7 Among these factors, hypertension is a significant and modifiable risk factor for cognitive impairment, and antihypertensive treatment could reduce the risk of both stroke and cognitive impairment. [8] [9] [10] Conversely, hypotension also causes or contributes to cognitive impairment and further promotes the progression of cognitive decline.
In patients with acute stroke, lower or higher blood pressure (BP) predicts poor prognosis and also increases the risk of PSCI. [14] [15] [16] What optimal BP levels in the early phase of stroke should be targeted to reduce the occurrence of PSCI is not yet conclusive. Furthermore, there are few data on the association between stroke subtypes and PSCI. The aim of this study was to investigate the impact of BP levels in the early phase of ischemic stroke and stroke subtypes on PSCI, as well as domain-specific cognitive impairments.
Methods

Study Design and Participants
All supporting data are available within the article and its online-only Data Supplement. We performed a single-center, prospective cohort study, which has been described previously. 17 Briefly, 986 consecutive patients with acute ischemic stroke were registered in the Stroke Registry database from January 2013 to June 2014. Patients meeting all of the following criteria were eligible: first-ever ischemic stroke within 24 hours of onset; identified signs of focal neurological dysfunction, the National Institutes of Health Stroke Scale scores ≥4 and the total scores ≥2 of the fifth motor arm and the sixth motor leg on National Institutes of Health Stroke Scale; ages between 40 and 75 years; and systolic BP (SBP) ≥140 mm Hg and diastolic BP (DBP) ≥90 mm Hg. Patient were excluded with any one of the following reasons: severe disturbance of consciousness identified by the level of consciousness on National Institutes of Health Stroke Scale score >1 (21 patients); the modified Rankin Scale score >1 before stroke onset (0 patient); severe mental disorders and dementia (7 patients); serious systemic diseases and expectancy life span <90 days (24 patients); alanine transaminase or aspartate aminotransferase >twice of the upper limit of normal or severe liver disease (23 patients); estimated glomerular filtration rate <30 mL/min per 1.73 m 2 or sever kidney disease (13 patients), aphasia (36 patients), uncooperative patients who could not perform the Montreal Cognitive Assessment (MoCA; 41 patients); and inappropriate patients who would transfer to other areas in 1 year or could not finish 12-month follow-up because of poor compliance (25 patients). Finally, 796 patients with acute ischemic stroke were eligible for this study. Study flow diagram of patients' enrollment was shown in Figure 1 . Approval was granted by the ethics committee of the First People's Hospital of Lianyungang City. Written informed consent was obtained from each patient or his/her proxy.
BP Lowering and Monitoring
The treatments complied with 2013 American Heart Association/ American Stroke Association guidelines for the early management of patients with acute ischemic stroke. 18 Moreover, BP measurement methodologies and antihypertensive strategies complied with 2013 European Society of Hypertension/European Society of Cardiology guidelines for the management of arterial hypertension. 19 In accordance to the national metrology standards, the mercury sphygmomanometer and the BP monitors have homogeneity by quality control personnel ahead. During the first 24 hours in the hospital, BP was recorded every 30 minutes within 6 hours and then every 2 hours from 6 to 24 hours using a noninvasive BP monitoring system (Philips SureSigns VM6 monitor; Royal Dutch Philips Electronics Ltd, Amsterdam, the Netherlands). Subsequently, supine BP was measured by trained nurses with a standard mercury sphygmomanometer on the nonparalyzed arm every 4 hours from days 1 to 7 (the detailed time points were 1 am, 5 am, 9 am, 1 pm, 5 pm, and 9 pm). At last, the mean values of SBP and DBP measurements within 7 days of stroke onset were used as SBP and DBP in the early phase, respectively.
Cognitive Assessment
Cognitive function was assessed by a trained neurologist using MoCA score. Cognitive impairment was considered present when MoCA scores were <26 for patients with ≥12 years of formal education, and <27 for patients with <12 years of formal education. 20, 21 Simultaneously, Hamilton Depression Scale-24 was evaluated to exclude the impact of poststroke depression on cognitive impairment. 22 All participants were followed up at 14 days, 3 months, 6 months, and 12 months by trained neurologists. Data on death and MoCA score were obtained. 
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Definition
Ischemic stroke was defined as the occurrence of stroke identified by radiographic diagnosis (computed tomography or magnetic resonance imaging scanning) and clinical diagnosis. 23 The early phase of ischemic stroke was defined as the time period within 7 days of symptom onset. According to the Trial of ORG 10172 in Acute Stroke Treatment classification, acute ischemic stroke was categorized into 5 subtypes: large artery atherosclerosis (LA), cardioembolism, small artery occlusion (SA), other determined cause, and undetermined cause. 24, 25 Moreover, according to Oxfordshire Community Stroke Project classification, acute ischemic stroke was divided into 4 subtypes: lacunar infarct, total anterior circulation infarct (TACI), partial anterior circulation infarct, and posterior circulation infarct (Table I in the online-only Data  Supplement) . 26, 27 Thrombolytic therapy was defined as intravenous administration of r-tPA (recombinant tissue-type plasminogen activator) within 4.5 hours of symptom onset or catheter-directed thrombolysis using r-tPA within 12 hours of symptom onset. The infarct volume on computed tomography/magnetic resonance imaging (diffusion-weighted imaging/fluid-attenuated inversion recovery) images was calculated using Pullicino equation (net infarct volume=L×W×H/2; L, W, and H were referred as the length, width, and height of infarct lesion, respectively).
28
Statistical Analysis
Continuous variables were presented as mean (SD) and were compared using 1-way ANOVA or Mann-Whitney U test. Categorical variables are expressed as frequency (percentage) and were compared using χ 2 test. Patients were divided into quintiles (Q1-Q5) according to SBP and DBP in the early phase, and the middle quintile Q3 was used as the reference. Variables were selectively included in the logistic regression models. Model 1 was adjusted for demographic characteristics, including age, sex, and education level. Model 2 was adjusted for the variables in model 1 plus more categorical variables, including medical history (smoking, drinking, hypertension, diabetes mellitus, hyperlipidemia, and atrial fibrillation), family history (hypertension, diabetes mellitus, coronary artery disease, stroke, and transient ischemic attack), posterior circulation infarction, and thrombolytic therapy. Model 3 was 
Results
Demographics and Clinical Characteristics
Baseline characteristics of 796 patients based on quintiles of BP were shown in Table II in the online-only Data Supplement.
There were no significant differences with regard to demographics, vascular risk factors, family history, and stroke features between these quintiles.
Prevalence of PSCI and the Score of MoCA Subdomain
As Table 1 shown, 186 patients were not included for cognitive assessment: 62 died, 22 were lost to follow-up, and 102 did not complete the assessment during the 12-month followup. After admission, the proportion of patients experienced PSCI was 18.97%, then increased to 30.28% at 14 days, (Figure 2A) . Similar association was observed in the quintiles of DBP levels ( Figure 2B ).
Correlation of Ischemic Stroke Subtype and PSCI Risk
The PSCI prevalence (77.34%) at 3 months was higher in LA subtype than that in the other subtypes (Table 3) . Total MoCA scores (17.21±4.86) and the subdomains scores of visuo-executive function (1.25±1.27), attention (4.01±1.32), and delayed recall (1.34±1.58) were lower in SA subtype than the other subtypes (Table 3) . After adjustment for multiple variables in model 3, LA subtype was associated with increased risk of PSCI (OR, 1.42; 95% CI, 1.06-1.90; P=0.031) at 3 months as compared with SA subtype ( Figure 3A) . The TACI subtype was also correlated with increased risk of PSCI (OR, 1.68; 95% CI, 1.32-2.15; P=0.001) at 3 months as compared with lacunar infarct subtype in model 3 ( Figure 3B ).
Discussion
Our study showed that lower BP (SBP/DBP, ≤127/82 mm Hg) or higher BP (SBP/DBP, ≥171/110 mm Hg) was associated with increased risk of PSCI at 3 months, maintaining optimal BP levels at SBP/DBP 143 to 158/93 to 102 mm Hg might be beneficial to reduce the risk of PSCI, and LA subtype and TACI subtype were associated with high PSCI risk.
Clinical trials have reported that the effects of lowering BP at the early phase of ischemic stroke on cognitive function. In the CATIS (China Antihypertensive Trial in Acute Ischemic Stroke), 4071 patients with acute ischemic stroke and elevated systolic BP (140-220 mm Hg) were randomly assigned to receive antihypertensive treatment or to discontinue all antihypertensive medications during hospitalization. 29 A preplanned ancillary study with 660 CATIS trial participants showed that a BP reduction strategy to achieve a target level of <140/90 mm Hg during hospitalization (within 7 days) has no effect on cognitive impairment as measured by either mini-mental state examination or MoCA at 3-month follow-up. 29 In the ENOS trial (Efficacy of Nitric Oxide in Stroke), 4011 patients with acute stroke and raised systolic BP (140-220 mm Hg) within 48 hours of onset were randomly assigned to 7 days of transdermal glyceryl trinitrate (5 mg/d) or to no glyceryl trinitrate (control group). 30 A subset of patients who were taking antihypertensive drugs before their stroke was also randomly assigned to continue or stop taking these drugs. 30 The results demonstrated that lowering of BP with glyceryl trinitrate for 7 days (mean SBP/DBP, 150-167/83-90) has no significant effects on cognitive function measured by modified telephone mini-mental state examination score (P=0.13), whereas continued antihypertensive treatment results in significantly lower cognition scores (P=0.013), compared with stopping treatment among patients with acute stroke at 90 days. 30 However, meta-analysis of the combined studies showed that lowering BP is associated with reduced cognitive decline (reduction in mini-mental state examination by 3-4 or more points, OR, 0.92; 95% CI, 0.85-1.00; P=0.04). 31 Our results demonstrated that lower or higher BP in the early phase of ischemic stroke 
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was significantly associated with the increased the risk of PSCI at 3 months. Normal regulation of BP is important for brain perfusion and prevention of cerebral injury. Theoretically, elevated BP has a harmful impact on cerebral blood flow and cerebrovascular autoregulation, resulting in the impaired cortical areas and cognitive decline. Whereas lowering BP causes the reduction in cerebral blood flow and brain tissue metabolism, contributing to the white matter disconnection and cognitive impairment. Meta-analysis is suggestive but not confirmatory of a U-shaped relationship between BP levels and outcome in acute stroke, where extremes of BP are related poorer outcome. 16 If there is such a U-shaped curve, it is important to identify what range of BP increments or decrements have significant effects on outcome. 16 Regrettably, there are few consensuses on BP levels in the early phase of ischemic stroke to decrease the risk of PSCI. The data from our study suggested that SBP/DBP 143 to 158/93 to 102 mm Hg might be associated with reduced risk of PSCI at 3 months.
Recent study suggested that not the total infarcted volume but the infarcted volume in the strategic areas, such as cortical limbic areas, heteromodal association areas, including the frontal cortex and the white matter, explains half of the variability of cognition and counts for much in the cognitive impairment after stroke. 32 The LA subtype or the TACI subtype, mostly caused by the occlusion of middle cerebral artery and anterior cerebral artery, leads to large infarcts in frontal, parieto-occipital, and temporal areas. 33 As a result, larger stroke volume in these areas is associated with higher risk of PSCI. Our study confirmed that both the LA subtype and the TACI subtype were associated with the increased risk of PSCI at 3 months.
We found that the prevalence of PSCI was elevated after 2 weeks of onset, reached its peak at 3 months, and then cognitive function was recovered gradually until 12 months. PSCI incorporates a variety of deficits in multiple domains, such as attention, executive functions, memory, language, and visuoperceptual abilities. 34 However, in different studies there is some variability in the most commonly impaired domains. One study reported that memory, visuoconstructional and executive functions are most commonly impaired in acute stroke patients even with excellent clinical recovery (modified Rankin Scale=0-1) at 3 months poststroke. 34 Another study revealed that the impairments in psychomotor speed, executive function, and visuospatial function are common in subacute and chronic stroke. 35 Furthermore, in patients with first-ever ischemic stroke, speed and attention are the most impaired domains after 3 months poststroke. 36 Intriguingly, our results showed that the impairments in visuo-executive function, attention, and delayed recall were most frequent in patients with ischemic stroke at 3 months, especially those with the SA subtype.
The white matter lesions are the common radiological manifestations of subclinical ischemic damage of the cerebral parenchyma because of the small cerebrovascular disease. 2 In the present study, white matter hyperintensity was assessed by the Fazekas Visual Rating Scale and scored by the Fazekas scale. The results demonstrated that higher Fazekas scores were significantly correlated with the increased risk of PSCI (Fazekas scores 3-4: hazard ratio, 2.16; 95% CI, 1.67-2.80; P<0.001; Fazekas scores 5-6: hazard ratio, 4.21; 95% CI, 3.04-5.81; P<0.001) during 12-month follow-up ( Figure I in the onlineonly Data Supplement). Importantly, low perfusion caused by small vessel disease primarily affects the associative areas of frontal and temporal cortices, which are involved in complex functions, such as decision-making and memory. 37 In small vessel disease, the infarct size is small but the total infarcted volume is huge, and the infarct sites are usually located in the associative areas of subcortical neural network. Thus, ischemic stroke patients with the SA subtype are susceptible to memory disorder and executive and visuospatial decline.
This study has limitations. First, the findings in the study were from a single center with a limited sample size and a relatively short follow-up period. Second, antihypertensive treatment was different in patients with ischemic stroke because of BP levels and comorbid conditions. However, we tried to minimize this likelihood by the subgroups analysis based on the quintiles of BP and Trial of ORG 10172 in Acute Stroke Treatment subtypes. Third, 102 patients could not complete the MoCA score and 22 patients were lost to follow-up, which might introduce some selection bias even though there were no significant differences on the distribution of the censored patients among the quintiles.
Conclusions
Lower or higher BP in the early phase of ischemic stroke was correlated with the increased risk of PSCI at 3 months, and this risk might be decreased by the maintenance of SBP/ DBP in the range of 143 to 158/93 to 102 mm Hg. Moreover, both the LA subtype and the TACI subtype were associated with the increased risk of PSCI, and visuo-executive function, attention, and delayed recall were reduced at 3 months especially in the SA subtype.
